Polypropylene
(PP) mesh has been used successfully for a long time
in clinical practice as an impressive prosthesis for ventral hernia
repair. To utilize a physical barrier for separating mesh from viscera
is a general approach for preventing adhesions in clinical practice.
However, a serious abdominal adhesion between the mesh and viscera
can possibly occur post-hernia, especially with the small intestine;
this can lead to a series of complications, such as chronic pain,
intestinal obstruction, and fistula. Thus, determining how to prevent
abdominal adhesions between the mesh and viscera is still an urgent
clinical problem. In this study, a dopamine-functionalized polysaccharide
derivative (oxidized-carboxymethylcellulose-g-dopamine,
OCMC-DA) was synthesized; this was blended with carboxymethylchitosan
(CMCS) to form a hydrogel (OCMC-DA/CMCS) in situ at the appropriate
time. The physical and chemical properties of the hydrogel were characterized
successfully, and its excellent biocompatibility was presented by
the in vitro cell test. The combination of this hydrogel and PP mesh
was used in laparoscopic surgery for repairing the abdominal wall
defect, where the hydrogel could become fixed in situ on the PP mesh
to form an anti-adhesion gel-mesh. The results showed that the gel-mesh
could prevent abdominal adhesions effectively in the piglet model.
Moreover, the histology and immunohistochemical staining proved that
the gel-mesh could effectively alleviate the inflammation reaction
and deposition of collagen around the mesh, and it did not disturb
the integration between mesh and abdominal wall. Thus, the gel-mesh
has superior tissue compatibility.